GKV Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.75M Buy
13,128
+911
+7% +$312K 1.53% 22
2026
Q1
$4.3M Buy
12,217
+248
+2% +$88.4K 1.61% 19
2025
Q4
$3.92M Buy
11,969
+1,224
+11% +$388K 1.47% 20
2025
Q3
$3.03M Sell
10,745
-220
-2% -$63.8K 1.2% 23
2025
Q2
$3.06M Buy
10,965
+200
+2% +$56.7K 1.35% 21
2025
Q1
$3.35M Sell
10,765
-80
-0.7% -$23.6K 1.67% 17
2024
Q4
$2.83M Buy
+10,845
New +$3.22M 1.15% 26

Other funds holding AMGN

GKV Capital Management's AMGN Position: Q2 2026 in Review

GKV Capital Management increased its Amgen (AMGN) stake by 7.5% in Q2 2026, buying an estimated $312K and bringing the position to 13,128 shares worth $4.75M. The position accounts for 1.53% of the portfolio, ranked #22.

GKV Capital Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,304 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • GKV Capital Management held 13,128 shares of Amgen worth $4.75M as of Q2 2026.
  • GKV Capital Management bought 911 Amgen shares in Q2 2026, an estimated $312K.
  • Amgen made up 1.53% of GKV Capital Management's portfolio in Q2 2026, its #22 holding.
  • GKV Capital Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,304 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on GKV Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.